We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+17.19%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$2.26B
AUM Growth
+$384M
Cap. Flow
+$115M
Cap. Flow %
5.09%
Top 10 Hldgs %
22.4%
Holding
443
New
33
Increased
160
Reduced
64
Closed
38

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$39.7M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$14.6M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$10.1M
4
WLK icon
Westlake Corp
WLK
+$8.6M
5
BKNG icon
Booking.com
BKNG
+$6.85M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$26.3M
2
CELG
Celgene Corp
CELG
+$20.8M
3
TIF
Tiffany & Co.
TIF
+$8.44M
4
SOXX icon
iShares Semiconductor ETF
SOXX
+$7.14M
5
ROP icon
Roper Technologies
ROP
+$5.77M

Sector Composition

Rank Sector Weight
1 Healthcare 30.75%
2 Technology 20.83%
3 Consumer Discretionary 14.53%
4 Financials 9.34%
5 Miscellaneous 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
126
Ultragenyx Pharmaceutical
RARE
$1.29B
$4.1M 0.18%
95,310
– –
IBM icon
127
IBM
IBM
$234B
$4.04M 0.18%
31,275
+2,343
+8% +$305K
IONS icon
128
Ionis Pharmaceuticals
IONS
$7.85B
$4.02M 0.18%
66,246
+3,046
+5% +$181K
MCHI icon
129
iShares MSCI China ETF
MCHI
$6.1B
$4M 0.18%
62,367
+40,000
+179% +$2.39M
ATVI
130
DELISTED
Activision Blizzard
ATVI
$3.97M 0.18%
67,000
+12,000
+22% +$664K
BPMC
131
DELISTED
Blueprint Medicines
BPMC
$3.87M 0.17%
47,600
– –
IQV icon
132
IQVIA
IQV
$44.4B
$3.86M 0.17%
25,060
+6,300
+34% +$920K
PTCT icon
133
PTC Therapeutics
PTCT
$5.48B
$3.82M 0.17%
78,300
– –
CDW icon
134
CDW
CDW
$19.2B
$3.76M 0.17%
26,280
+7,133
+37% +$944K
HYG icon
135
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.1B
$3.73M 0.17%
42,450
– –
CAT icon
136
Caterpillar
CAT
$360B
$3.72M 0.16%
25,160
+12,100
+93% +$1.69M
ECL icon
137
Ecolab
ECL
$77B
$3.7M 0.16%
19,329
-7,481
-28% -$1.42M
ITRI icon
138
Itron
ITRI
$4.04B
$3.64M 0.16%
43,450
– –
REGN icon
139
Regeneron Pharmaceuticals
REGN
$79.7B
$3.55M 0.16%
9,500
– –
VMW
140
DELISTED
VMware, Inc
VMW
$3.45M 0.15%
22,400
+11,000
+96% +$1.72M
AMP icon
141
Ameriprise Financial
AMP
$49.4B
$3.42M 0.15%
20,500
+1,300
+7% +$201K
EXEL icon
142
Exelixis
EXEL
$14.1B
$3.39M 0.15%
186,800
– –
PLUG icon
143
Plug Power
PLUG
$2.86B
$3.34M 0.15%
1,085,000
+735,000
+210% +$2.23M
JNJ icon
144
Johnson & Johnson
JNJ
$644B
$3.24M 0.14%
22,191
-36,629
-62% -$4.97M
RUN icon
145
Sunrun
RUN
$2.02B
$3.19M 0.14%
225,200
-88,700
-28% -$1.32M
ZTO icon
146
ZTO Express
ZTO
$15.4B
$3.15M 0.14%
134,991
+40,545
+43% +$876K
BLUE
147
DELISTED
bluebird bio
BLUE
$3.14M 0.14%
2,744
– –
SPWR
148
DELISTED
SunPower Corporation Common Stock
SPWR
$3.09M 0.14%
592,476
+167,970
+40% +$934K
XOM icon
149
ExxonMobil
XOM
$696B
$3.01M 0.13%
43,100
– –
C icon
150
Citigroup
C
$228B
$2.96M 0.13%
37,100
+7,010
+23% +$518K
4 5
6
7 8

Similar funds

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
WI
WealthNavi Inc Shinagawa-Ku, Tokyo, Japan $12.8B AUM 19.73% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Erste Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Erste Asset Management held 443 positions worth $2.26B, up 20% from $1.88B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Erste Asset Management deployed $115M of net new capital in Q4 2019, opening 33 new positions and adding to 160 existing holdings. Its largest new stake was Westlake Corp: 128,000 shares worth $8.83M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $26.3M trimmed.

  • Erste Asset Management's largest Q4 2019 buy was Westlake Corp: 128,000 shares worth $8.83M.
  • Erste Asset Management added most to Biogen in Q4 2019, an estimated $39.7M increase.
  • Erste Asset Management's biggest Q4 2019 reduction was Vertex Pharmaceuticals, cutting an estimated $26.3M.
  • Erste Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $20.8M.
  • Erste Asset Management's ten largest holdings make up 22% of its $2.26B portfolio in Q4 2019.
  • Erste Asset Management opened 33 new positions and closed 38 in Q4 2019.
  • Erste Asset Management's portfolio value rose 20% quarter-over-quarter to $2.26B.

Based on Erste Asset Management's 13F filing for Q4 2019, filed 22 Nov 2024.